BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23437292)

  • 1. Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.
    Sharma A; Krause A; Xu Y; Sung B; Wu W; Worgall S
    PLoS One; 2013; 8(2):e56996. PubMed ID: 23437292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
    Worgall S; Krause A; Qiu J; Joh J; Hackett NR; Crystal RG
    J Virol; 2007 Dec; 81(24):13801-8. PubMed ID: 17942539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
    Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
    Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.
    Krause A; Whu WZ; Qiu J; Wafadari D; Hackett NR; Sharma A; Crystal RG; Worgall S
    Clin Exp Immunol; 2013 Aug; 173(2):230-41. PubMed ID: 23607394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.
    Krause A; Joh JH; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG; Worgall S
    J Virol; 2006 Jun; 80(11):5523-30. PubMed ID: 16699033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.
    Gu L; Farrow AL; Krendelchtchikov A; Matthews QL
    J Vis Exp; 2015 May; (99):e52655. PubMed ID: 25993057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
    Matthews QL; Yang P; Wu Q; Belousova N; Rivera AA; Stoff-Khalili MA; Waehler R; Hsu HC; Li Z; Li J; Mountz JD; Wu H; Curiel DT
    Virol J; 2008 Aug; 5():98. PubMed ID: 18718011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB
    Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
    Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
    Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
    PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy.
    Gu L; Krendelchtchikova V; Krendelchtchikov A; Farrow AL; Derdeyn CA; Matthews QL
    Virology; 2016 Jan; 487():75-84. PubMed ID: 26499044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
    Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
    Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid.
    Lanzi A; Ben Youssef G; Perricaudet M; Benihoud K
    Vaccine; 2011 Feb; 29(7):1463-71. PubMed ID: 21184856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.